Clinical trial
Magnesium Sulfate vs Placebo for Placental Abruption
NCT00186069 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186069 |
|---|---|
| Title | Magnesium Sulfate vs Placebo for Placental Abruption |
| Official title | Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption |
| Lead sponsor | Stanford University, Other |
| Collaborators | Santa Clara Valley Medical Center |
| Status | Completed |
| Study type | Interventional |
| Conditions | Abruptio Placentae |
| Intervention type | Drug, Other |
| Interventions | Magnesium Sulfate, Normal Saline |
| Enrollment | 30 |
| Start date | Mar 1, 2004 |
| Primary completion | Jun 1, 2014 |
| Completion | Nov 1, 2017 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: